How many companion animals are diagnosed with cancer each year?

It's estimated that 70-80 million dogs and 74-96 million cats are owned in the United States.

Every day 10,000 dogs and 6,000 cats are diagnosed with cancer.


PetLife Pharmaceuticals, Inc., (OTCQB:PTLF) is launching a new generation of all natural veterinary cancer medications and nutraceuticals called "VitalZul for Pets™", which utilizes extracts of the venom of the Caribbean Blue Scorpion. The company’s mission is to bring several non-invasive treatments to market with the goal of improving the quality of life in our companion animals. The anticipated registration of an FDA approved drug, “VitalZul™”, for the treatment of cancer in animals, as well as the introduction of nutraceuticals, food, and pet treats, are all in the works today.

New frontier in pet oncological treatment utilizing the venom of the Caribbean Blue Scorpion

PetLife Pharmaceuticals is introducing a new breakthrough pet cancer drug that is anticipated to begin FDA trials in the upcoming months. The drug is an all-natural compound. The FDA trials are estimated to take approximately 18-24 months. PetLife Pharmaceuticals, Inc. is a publicly traded company. The stock symbol is PTLF on the OTCQB market. PetLife is a new biotech company developing products to address disease in our companion pets.

What is VitaZul™?

The primary ingredients of VitalZul’™ is an innovative potentiated bio-active peptide extracted from the Caribbean Blue Scorpion (Rhopalurus Junceus) used to treat dogs and cats diagnosed with cancer

Important Facts to Know

• 1/4 of dogs and 1/5 of cats will develop cancer in their lifetime!
• Cancer is the #1 disease related cause of death in dogs in the US
• Cancer accounts for almost 50% of deaths in pets older than 10 years old
• Conventional treatment can cost SEVERAL thousands of dollars, forcing pet owners to watch their pet slowly deteriorate

Clinical Test Trial Results

• No signs of toxicity or complications observed during clinical use
• Binds preferentially to abnormal cells
• Reduces the painful side-effects of chemotherapy and radiation
• Increased appetite and energy level

Clinical Studies

Dr. Mitchell-Navratik has been treating a 15-year-old feline with primary pulmonary adenocarcinoma for seven weeks and has detailed her observations with X-rays and testimonials- CLICK here

NEWS

February 2017
PetAge www.petage.com & Baltimore, MD citybizlist.com - PetLife Pharmaceuticals Plans to Acquire Healthy Life Pets Brand
View Articles

November 2014
California based Company's Cancer Fighting Serum made from Peptides found in Scorpion Venom - Nightline News

July 23 2014
Doctor explains how Scorpion Venom could Help Fight Cancer - FOX News Insider

August 04 2014
Bee, Scorpion & Snake Venom may hold Cancer Cure - CNN

FEATURED PRESS

March 21, 2017
PetLife Supersedes Expectations for the Acquisition of Dr. Geoff’s Real Food for Pets
March 21, 2017 07:00 AM Eastern Daylight Time
HANCOCK, Md.--(BUSINESS WIRE)--PetLife Pharmaceuticals, Inc. (OTCQB:PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, announced today that it has proceeded to the next expected stage of acquiring Dr. Geoff’s Real Food for Pets™ and simultaneously has expanded plans for a national rollout.
VIEW PRESS RELEASE

March 7, 2017
PetLife Pharmaceuticals Provides an Eye-Opening View on a Recession Resistive Industry - released today an overview of the $63 billion companion pet healthcare industry. Empty nesters, reduced fertility, and pet owners prioritizing pet care over their own expenses all contribute to the resiliency of the pet care industry. PetLife’s continuous development of multiple product lines aims to serve the growing companion pet healthcare market, bolstering its market reach and thereby solidifying the company both on a revenue/financial point of view as a natural, solution-focused company.
VIEW PRESS RELEASE

February 28, 2017
PetLife Pharmaceuticals Signs Letter of Intent to Acquire Healthy Life Pets Brand - announced today that it signed a Letter of Intent to acquire the assets of Healthy Life Pets. Most commonly known as Dr. Geoff’s Real Food for Pets™, assets in this brand include six SKUs of retail-ready products, including both canned food and antioxidant supplements.
VIEW PRESS RELEASE

January 10, 2017
PetLife Pharmaceuticals reports the First of Three Preclinical Studies in their pre-INAD Process for Vitalzul. Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions across Multiple Dosing Levels.
VIEW PRESS RELEASE

Click here to VIEW ALL PRESS RELEASE INFORMATION
Click here to load this Caspio Cloud Database